Претраживање
Приказ резултата 21-30 од 42
Chemical characterization and antimicrobial activity of Juglans nigra L. nut and green husk / Хемијска карактеризација и антимикробна активност орашастог плода и зелене љуске Juglans nigra L.
(Serbian Chemical Society, 2023)
Juglans nigra (Black walnut) is a source of health-supporting biologically active compounds used in traditional medicine. The investigation of bioactive compounds in black walnut could lead to its broader application, as ...
Evaluating ground glass opacities (GGO) in the COVID-19 era. Do autoantibodies help?
(Journal of Infection in Developing Countries, 2022)
Introduction: COVID-19 is an infectious disease, caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and there have been outbreaks worldwide. The presentation may include unspecific and mild symptoms, ...
Lidocaine Clearance as Pharmacokinetic Parameter of Metabolic Hepatic Activity in Patients with Impaired Liver / Klirens lidokaina kao farmakokinetički parametar metaboličke aktivnosti kod pacijenata sa oštećenjem jetre
(Beograd : Društvo medicinskih biohemičara Srbije, 2023)
Background: The study aimed to estimate lidocaine (LID)
pharmacokinetic parameter values in patients with
impaired liver function, level of correlation between the
pharmacokinetic parameters and Child-Pugh class and
change ...
Pharmacokinetic characterization, benefits and barriers of subcutaneous administration of monoclonal antibodies in oncology
(SAGE Publications Ltd, 2023)
Objective: Therapeutic monoclonal antibodies in oncology are slowly becoming the dominant treatment option for many different cancer types. The main route of administration, infusion, requires extensive product preparations, ...
Development and validation of RP-HPLC method for quantification of trace levels of topical corticosteroids in ambiphilic cream
(Akademiai Kiado ZRt., 2023)
Corticosteroids are anti-inflammatory and immunosuppressant drugs. Topical corticosteroids formulations (ointments, creams, gels) are used in the treatment of different types of dermatitis and urticaria. Considering their ...
Principal component analysis of the oxidative stress, inflammation, and dyslipidemia influence in patients with different levels of glucoregulation / Glavna komponentna analiza uticaja oksidativnog stresa, inflamacije i dislipidemije kod pacijenata sa različitim nivoom glikoregulacije
(Society of Medical Biochemists of Serbia, 2023)
Background: The aim of the study was to explore the mutual relationship between oxidative stress, inflammation and
metabolic biomarkers in subjects with prediabetes (PRE),
newly diagnosed type 2 diabetes patients (NT2D) ...
The utility of serum amyloid a and other acute-phase reactants determination in ambulatory care COVID-19 patients / Značaj određivanja serumskog amiloida A i drugih reaktanata akutne faze kod ambulantnih pacijenata sa COVID-19
(Society of Medical Biochemists of Serbia, 2023)
Background: The unpredictable course of Coronavirus
Disease 19 (COVID-19) is making good severity assessment tools crucial. This study aimed to assess the usefulness of serum amyloid A (SAA) and other acute-phase
reactants ...
Medicines Policy and Drugstores in Serbia Until the Second World War / Политика лекова и дрогерије у Србији до Другог светског рата
(Institute for Recent History of Serbia, 2023)
The paper analyzes the eff ects of medicines policy on
the functional separation of pharmacy and drugstore businesses
from the early 19th century to the Second World War. Attempts
to maintain personal and professional ...
Application of liquid chromatography in defining the interaction of newly synthesized chalcones and related compounds with human serum albumin / Примена течне хроматографије у дефинисању интеракција новосинтетисаних халкона и сродних супстанци са хуманим серумским албуминима
(Srpsko hemijsko društvo, Beograd, 2023)
Defining the interaction of newly synthesized compounds with plasma proteins is an important step in the drug development process. Chromatographic techniques can be successfully used in predicting the biopharmaceutical ...